Cancer Biology & Medicine (Jun 2012)

Combined Therapy against Recurrent Hemangiopericytoma: A Case Report

  • Xiao-dong Li,
  • Jing-ting Jiang,
  • Chang-ping Wu

DOI
https://doi.org/10.3969/j.issn.2095-3941.2012.02.012
Journal volume & issue
Vol. 9, no. 2
pp. 141 – 143

Abstract

Read online

Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, ChinaA patient with a seven-year history of recurrent metastatic hemangiopericytoma (HPC) was admitted. During his treatment, he received surgical resection, radiotherapy, radiofrequency hyperthermia and chemotherapy using combined doxorubicin, dacarbazin, vincristine, ginsenoside Rg3, and recombinant human endostatin. This synergistic method provides an encouraging model for treating HPC.

Keywords